SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-023641
Filing Date
2024-02-14
Accepted
2024-02-14 16:11:03
Documents
17
Period of Report
2024-02-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm246214d1_8k.htm   iXBRL 8-K 33872
2 EXHIBIT 1.1 tm246214d1_ex1-1.htm EX-1.1 257272
3 EXHIBIT 5.1 tm246214d1_ex5-1.htm EX-5.1 10359
7 GRAPHIC tm246214d1_ex5-1img001.jpg GRAPHIC 3122
  Complete submission text file 0001104659-24-023641.txt   549174

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA immu-20240213.xsd EX-101.SCH 3015
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE immu-20240213_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE immu-20240213_pre.xml EX-101.PRE 22359
18 EXTRACTED XBRL INSTANCE DOCUMENT tm246214d1_8k_htm.xml XML 3611
Mailing Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341
Business Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

IRS No.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39580 | Film No.: 24638175
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)